In patients with HNSCC, the loss of RIPK1 and RIPK3 function caused by hypermethylation of the promoter is closely related to metastatic disease and poor prognosis [38, 39]. The gene discussed is RIPK3; the disease is head and neck squamous cell carcinoma.